57 authors at 14 institutions in 8 countries.
Thais GazziLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.
Benjamin BrenneckeLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.
Kenneth AtzRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Claudia KornRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
David SykesFaculty of Medicine & Health Sciences, University of Nottingham Nottingham NG7 2UH England UK.
Gabriel Forn-CuniLeiden University Einsteinweg 55 2333 CC Leiden the Netherlands.
Patrick PfaffLaboratorium für Organische Chemie, Eidgenössische Technische Hochschule Zürich Vladimir-Prelog-Weg 3 8093 Zürich Switzerland.
Matthias V WestphalLaboratorium für Organische Chemie, Eidgenössische Technische Hochschule Zürich Vladimir-Prelog-Weg 3 8093 Zürich Switzerland.
Yelena MostinskiLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.
Leonard MachLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.
Malgorzata Wasinska-KalwaLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.
Marie WeiseLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.
Bradley L HoareFaculty of Medicine & Health Sciences, University of Nottingham Nottingham NG7 2UH England UK.
Tamara MiljušFaculty of Medicine & Health Sciences, University of Nottingham Nottingham NG7 2UH England UK.
Maira MexiFaculty of Medicine & Health Sciences, University of Nottingham Nottingham NG7 2UH England UK.
Nicolas RothWilliam Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London London EC1M 6BQ England UK.
Eline J KoersFaculty of Medicine & Health Sciences, University of Nottingham Nottingham NG7 2UH England UK.
Wolfgang GubaRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
André AlkerRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Arne C RuferRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Eric A KusznirRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Sylwia HuberRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Catarina RaposoRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Elisabeth A ZirwesRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Anja OsterwaldRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Anto PavlovicRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Svenja MoesRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Jennifer BeckRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Matthias NettekovenRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Irene Benito-CuestaFaculty of Experimental Sciences, Universidad Francisco de Vitoria Pozuelo de Alarcón 28223 Madrid Spain.
Teresa GrandeFaculty of Experimental Sciences, Universidad Francisco de Vitoria Pozuelo de Alarcón 28223 Madrid Spain.
Faye DrawnelRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Gabriella WidmerRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Daniela HolzerRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Tom van der WelDepartment of Molecular Physiology, Leiden Institute of Chemistry, Leiden University 2333 CC Leiden the Netherlands.
Michael HonerRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Jürgen FingerleRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Jörg ScheffelDermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin Berlin Germany.
Klaus GawrischNational Institute on Alcohol Abuse and Alcoholism, National Institutes of Health Rockville MD 20852 USA.
Julián RomeroFaculty of Experimental Sciences, Universidad Francisco de Vitoria Pozuelo de Alarcón 28223 Madrid Spain.
Cecilia J HillardDepartment of Pharmacology and Toxicology, Neuroscience Research Center, Medical College of Wisconsin Milwaukee WI 53226 USA.
Zoltan V VargaNational Institute on Alcohol Abuse and Alcoholism, National Institutes of Health Rockville MD 20852 USA.
Mario van der SteltDepartment of Molecular Physiology, Leiden Institute of Chemistry, Leiden University 2333 CC Leiden the Netherlands.
Pal PacherNational Institute on Alcohol Abuse and Alcoholism, National Institutes of Health Rockville MD 20852 USA.
Jürg GertschInstitute of Biochemistry and Molecular Medicine, University of Bern 3012 Bern Switzerland.
Christoph UllmerRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.
Peter J McCormickWilliam Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London London EC1M 6BQ England UK.
Sergio OddiFaculty of Veterinary Medicine, University of Teramo 64100 Teramo European Italy.
Mauro MaccarroneEuropean Center for Brain Research (CERC), Santa Lucia Foundation 00179 Rome Italy.
Dmitry B VeprintsevFaculty of Medicine & Health Sciences, University of Nottingham Nottingham NG7 2UH England UK.
Erick M CarreiraLaboratorium für Organische Chemie, Eidgenössische Technische Hochschule Zürich Vladimir-Prelog-Weg 3 8093 Zürich Switzerland.
Uwe GretherRoche Pharma Research & Early Development, Roche Innovation Center Basel F. Hoffmann-La Roche Ltd. 4070 Basel Switzerland uwe.grether@roche.com.